Dataset from A Study of Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute TReaTment of MigrAiNe: A Randomized, Double-blind, Placebo-controlled Parallel Group Study (SPARTAN)
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009123
下载链接
链接失效反馈官方服务：
资源简介：
This is a prospective randomized, double-blind, placebo-controlled study in participants with
disabling migraine (Migraine Disability Assessment (MIDAS) score ≥ 11).
创建时间：
2024-11-26
